tm
Seeing Is Believing
tm
Seeing Is Believing
ELDN is currently covered by 1 analysts with an average price target of $7. This is a potential upside of $4.7 (204.35%) from yesterday's end of day stock price of $2.3.
Eledon Pharmaceuticals's activity chart (see below) currently has 11 price targets and 19 ratings on display. The stock rating distribution of ELDN is 100% BUY.
Highest price target for ELDN is $7, Lowest price target is $7, average price target is $7.
Most recent stock forecast was given by THOMAS SMITH from LEERINK on 22-Jun-2026. First documented stock forecast 08-Feb-2021.
Currently out of the existing stock ratings of ELDN, 1 are a BUY (100%).
Analyst name
Rating
Current price target
Potential Upside
Previous price target
Date of last PT
Price targets met ratio
Average potential upside
Average Days to Hit Target
Performance score
Buy Since 08-Feb-2021
$7
$4.7 (204.35%)
$7
4 months 4 days ago
(22-Jun-2026)
0/4 (0%)
$3.19 (83.73%)
Buy Since 18-Jun-2025
$9
$5.22 (138.10%)
$9
1 years 1 months 24 days ago
(02-Sep-2025)
0/2 (0%)
$6.45 (252.94%)
Buy Since 25-Nov-2021
$16
$12.22 (323.28%)
1 years 11 months 6 days ago
(20-Nov-2024)
0/2 (0%)
$12.15 (315.58%)
Buy Since 22-Mar-2021
$9
$6.7 (291.30%)
$15
3 years 2 months 4 days ago
(22-Aug-2023)
0/3 (0%)
$7.53 (512.24%)
Which analyst most recently updated their price target on ELDN (Eledon Pharmaceuticals)?
Which analyst has the most public recommendations on ELDN (Eledon Pharmaceuticals)?
Which analyst is the currently most bullish on ELDN (Eledon Pharmaceuticals)?
Which analyst is the currently most reserved on ELDN (Eledon Pharmaceuticals)?
